• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中能量代谢的下调是神经元对微环境的一种保护反应。

Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment.

机构信息

CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.

出版信息

J Alzheimers Dis. 2012;28(2):389-402. doi: 10.3233/JAD-2011-111313.

DOI:10.3233/JAD-2011-111313
PMID:22008267
Abstract

A central issue in the field of Alzheimer's disease (AD) is to separate the cause from the consequence among many observed pathological features, which may be resolved by studying the time evolution of these features at distinctive stages. In this work, comprehensive analyses on transcriptome studies of human postmortem brain tissues from AD patients at distinctive stages revealed stepwise breakdown of the cellular machinery during the progression of AD. At the early stage of AD, the accumulation of amyloid-β oligomers and amyloid plaques leads to the down-regulation of biosynthesis and energy metabolism. At the intermediate stage, the progression of the disease leads to enhanced signal transduction, while the late stage is characterized by elevated apoptosis. The down-regulation of energy metabolism in AD has been considered by many as a consequence of mitochondrion damage due to oxidative stress. However, the non-existence of enhanced response to oxidative stress and the revelation of intriguing down-regulation patterns of the electron-transport chain at different stages suggest otherwise. In contrast to the damage-themed hypothesis, we propose that the down-regulation of energy metabolism in AD is a protective response of the neurons to the reduced level of nutrient and oxygen supply in the microenvironment. The elevated apoptosis at the late stage of AD is triggered by the conflict between the low level of energy metabolism and high level of regulatory and repair burden. This new hypothesis has significant implication for pharmaceutical intervention of Alzheimer's disease.

摘要

阿尔茨海默病(AD)领域的一个核心问题是将许多观察到的病理特征中的病因与后果区分开来,这可以通过研究这些特征在不同阶段的时间演变来解决。在这项工作中,对 AD 患者不同阶段死后脑组织转录组研究的综合分析揭示了 AD 进展过程中细胞机制的逐步崩溃。在 AD 的早期,淀粉样β寡聚体和淀粉样斑块的积累导致生物合成和能量代谢的下调。在中期,疾病的进展导致信号转导增强,而晚期则以凋亡增加为特征。AD 中能量代谢的下调被许多人认为是由于氧化应激导致线粒体损伤的结果。然而,氧化应激增强反应的不存在以及不同阶段电子传递链引人入胜的下调模式的揭示表明并非如此。与损伤主题假说相反,我们提出 AD 中能量代谢的下调是神经元对微环境中营养和氧气供应减少的一种保护反应。AD 晚期的凋亡增加是由低水平的能量代谢和高水平的调节和修复负担之间的冲突触发的。这一新假说对阿尔茨海默病的药物干预具有重要意义。

相似文献

1
Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment.阿尔茨海默病中能量代谢的下调是神经元对微环境的一种保护反应。
J Alzheimers Dis. 2012;28(2):389-402. doi: 10.3233/JAD-2011-111313.
2
Pathophysiology of neuronal energy crisis in Alzheimer's disease.阿尔茨海默病中神经元能量危机的病理生理学
Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6.
3
Brain aging and Alzheimer's disease; use it or lose it.大脑衰老与阿尔茨海默病;用进废退。
Prog Brain Res. 2002;138:343-73. doi: 10.1016/S0079-6123(02)38086-5.
4
Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.活体转基因小鼠大脑中阿尔茨海默病病理学的磁共振成像:阿尔茨海默病研究的新工具。
Neuroscientist. 2007 Feb;13(1):38-48. doi: 10.1177/1073858406295610.
5
Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.行为应激通过产生代谢性氧化应激加速Tg2576小鼠大脑中的斑块发病机制。
J Neurochem. 2009 Jan;108(1):165-75. doi: 10.1111/j.1471-4159.2008.05769.x. Epub 2008 Nov 21.
6
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.阿尔茨海默病中的晚期糖基化终产物及其受体 RAGE。
Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22.
7
Alzheimer's disease: cholesterol a menace?阿尔茨海默病:胆固醇是一个威胁吗?
Brain Res Bull. 2011 Aug 10;86(1-2):1-12. doi: 10.1016/j.brainresbull.2011.06.006. Epub 2011 Jul 1.
8
Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.阿尔茨海默病与“缺失”假说:β-淀粉样蛋白对内皮细胞和神经元毒性的机制
Med Hypotheses. 2005;65(1):123-37. doi: 10.1016/j.mehy.2004.08.031.
9
Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease.
Acta Neuropathol. 2002 Apr;103(4):377-83. doi: 10.1007/s00401-001-0476-6. Epub 2001 Dec 15.
10
Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.阿尔茨海默病和路易体痴呆患者大脑皮质中代谢型谷氨酸受体/磷脂酶C信号通路受损与阿尔茨海默病相关变化的阶段相关。
Neurobiol Dis. 2005 Dec;20(3):685-93. doi: 10.1016/j.nbd.2005.05.001. Epub 2005 Jun 8.

引用本文的文献

1
Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction.葡萄糖富集缩短了表达人tau蛋白的秀丽隐杆线虫的寿命并促进tau蛋白磷酸化,不受O-β-氨基葡萄糖酰化诱导的影响。
J Mol Med (Berl). 2025 Mar;103(3):327-338. doi: 10.1007/s00109-025-02522-3. Epub 2025 Feb 10.
2
Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase () protects against amyloid beta toxicity in model of Alzheimer's disease.抑制核心代谢酶二氢硫辛酰胺脱氢酶()可在阿尔茨海默病模型中预防β-淀粉样蛋白毒性。
Genes Dis. 2020 Aug 20;8(6):849-866. doi: 10.1016/j.gendis.2020.08.004. eCollection 2021 Nov.
3
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
细胞类型特异性线粒体功能障碍在阿尔茨海默病发病机制中的作用。
BMB Rep. 2019 Dec;52(12):679-688. doi: 10.5483/BMBRep.2019.52.12.282.
4
miRDRN-miRNA disease regulatory network: a tool for exploring disease and tissue-specific microRNA regulatory networks.miRDRN-微小RNA疾病调控网络:一种探索疾病和组织特异性微小RNA调控网络的工具。
PeerJ. 2019 Aug 6;7:e7309. doi: 10.7717/peerj.7309. eCollection 2019.
5
Dihydrolipoamide dehydrogenase suppression induces human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer's Disease.在阿尔茨海默病的秀丽隐杆线虫模型中,二氢硫辛酰胺脱氢酶抑制通过提高全身葡萄糖水平诱导人tau蛋白磷酸化。
Exp Brain Res. 2018 Nov;236(11):2857-2866. doi: 10.1007/s00221-018-5341-0. Epub 2018 Jul 28.
6
The frontline of immune response in peripheral blood.外周血中免疫反应的前沿。
PLoS One. 2017 Aug 3;12(8):e0182294. doi: 10.1371/journal.pone.0182294. eCollection 2017.
7
Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer's disease.基因表达分析揭示了阿尔茨海默病中免疫和代谢途径的失调。
Oncotarget. 2016 Nov 8;7(45):72469-72474. doi: 10.18632/oncotarget.12505.
8
Towards Personalized Intervention for Alzheimer's Disease.迈向阿尔茨海默病的个性化干预
Genomics Proteomics Bioinformatics. 2016 Oct;14(5):289-297. doi: 10.1016/j.gpb.2016.01.006. Epub 2016 Sep 28.
9
Insights into the fluoride-resistant regulation mechanism of Acidithiobacillus ferrooxidans ATCC 23270 based on whole genome microarrays.基于全基因组芯片对嗜酸氧化亚铁硫杆菌ATCC 23270耐氟调控机制的洞察
J Ind Microbiol Biotechnol. 2016 Oct;43(10):1441-53. doi: 10.1007/s10295-016-1827-6. Epub 2016 Aug 12.
10
Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease.血管性痴呆和阿尔茨海默病外周血中的常见衰老特征
Mol Neurobiol. 2016 Aug;53(6):3596-3605. doi: 10.1007/s12035-015-9288-x. Epub 2015 Jun 23.